Schilsky, M. L., Czlonkowska, A., Zuin, M., Cassiman, D., Twardowschy, C., Poujois, A., Gondim, F. d. A. A., Denk, G., Cury, R. G., Ott, P., Moore, J., Ala, A., D'Inca, R., Couchonnal-Bedoya, E., D'Hollander, K., Dubois, N., Kamlin, C. O. F., Weiss, K. H., , , To, U., Patel, A., Hettiarachchi, D., Giorgini, A., Monico, S., Litwin, T., Piechal, A., Skowronska, M., Lachaux, A., Belmalih, A., Boogers, A., Mohr, I., Langel, A., Freitas, C., Barbosa, E. R., Sandahl, T. D., Gerdes, L., Obadia, A., Rahli, D., & Cosgrove, J. (2022). trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. Lancet gastroenterology and hepatology, 7, 1092–1102. http://access.bl.uk/ark:/81055/vdc_100169738197.0x000003